DIA vs TRAW
DIA (DIA) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
DIA (DIA) common stock.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
DIA does not have a complete income-statement cache yet.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
DIA currently screens at market cap $0. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the DIA and TRAW stock pages for the full models.
Not investment advice.